Harvard Catalyst Biostatistics Program: 2024 Highlights
The Harvard Catalyst Biostatistics Program had an eventful year.
The Program saw many successes in 2024. Our biostatistician and bioinformatician consultants provided over 780 consultations. Investigators across Harvard and Harvard-affiliated hospitals were helped on various issues, ranging from designing a study or a clinical trial, to receiving advice on specific analytic techniques or the interpretation of results, or simply exploring the feasibility of a pilot study, to name a few.
During the year, we offered a variety of continuing education opportunities for the Harvard community at our Short Courses and engaged students, postdoctoral trainees, faculty and researchers in stimulating discussions at our Journal Club meetings. In April we held our annual Harvard Catalyst Biostatistics Symposium entitled “Challenges and Opportunities in the Choice of Outcome Measures in Clinical Research”. The symposium focused on the current challenges in choosing outcomes for clinical studies that evaluate treatments for disease. A panel of distinguished speakers discussed the issues around creating a composite patient outcome that provides a more clinically relevant and informative evaluation and synthesis of treatment benefit, safety, and patient quality of life. We are now in the planning stages for another symposium in April 2025; further details and registration information will be available in the New Year.
As we welcome in 2025, we invite you to stay in contact and hope to see you at our future events. If you’re not already on our mailing list, we invite you to join by sending a note to our Program Manager, Jocelyn Kasper, at CatalystBiostats@catalyst.harvard.edu.
Best wishes and happy holidays from all of us at the Harvard Catalyst Biostatistics Program!
Garrett Fitzmaurice and Jocelyn Kasper
